What Meeting Planners Need to Know About the New FDA COVID-19 Vaccine Guidelines
As fall and winter approach, meeting planners face an important update regarding COVID-19 vaccination policies. The Food and Drug Administration (FDA) has revised its authorization of updated COVID-19 vaccines for 2025 and 2026. These changes could have implications for corporate events, conferences, and large-scale gatherings.
Key Updates From the FDA
-
Eligibility limited to higher-risk groups
-
People 65 and older
-
Adults and children with certain underlying health conditions (including asthma, diabetes, high blood pressure, obesity, chronic lung or kidney disease, depression, weakened immune systems, and sedentary lifestyle factors)
-
-
Healthy adults under 65 and healthy children may still receive the vaccine, but only after consulting a healthcare provider.
-
Pregnant individuals remain a complex case: the FDA lists pregnancy as a risk factor, but the CDC no longer routinely recommends vaccination for all healthy pregnant women.
Why This Matters for Meetings and Events
These changes may affect vaccination access, insurance coverage, and on-site health protocols:
-
Access barriers: Healthy adults under 65 may find it more difficult to secure vaccination before an event, particularly if they do not have a regular healthcare provider.
-
Insurance considerations: While some insurers have said they’ll continue covering the vaccines, coverage is no longer guaranteed across the board. Out-of-pocket costs may exceed $200 per dose.
-
Conflicting guidance: Professional associations like the Infectious Diseases Society of America and the American Academy of Pediatrics continue to recommend vaccination for broader groups, including children and pregnant people, despite the new FDA limits.
-
Workforce concerns: Even healthy employees may want access to vaccination to reduce the risk of missing work, developing long COVID, or exposing vulnerable family members.
What Meeting Planners Should Do Now
-
Communicate early with attendees
-
Provide clear, neutral updates on eligibility changes so participants know what to expect.
-
Remind high-risk individuals to consult their healthcare providers well ahead of travel.
-
-
Review event health policies
-
Reassess whether proof of vaccination will still be required or recommended.
-
Consider reinforcing other protective measures such as rapid testing, improved ventilation, or on-site medical support.
-
-
Coordinate with venues and vendors
-
Ask venues if they plan to stock updated COVID vaccines (many pharmacies and health systems are still waiting on CDC guidance before administering them).
-
Ensure that liability and compliance policies align with both FDA guidance and local regulations.
-
-
Plan for contingencies
-
Build flexibility into contracts and budgets in case of illness-related cancellations or increased absenteeism.
-
Factor in on-site clinical support to help identify and respond to potential COVID cases quickly.
-
Bottom Line for Meeting Planners
The new COVID-19 vaccine restrictions for 2025 add another layer of complexity to event safety planning. While eligibility has narrowed, many attendees will still expect reassurance that meetings are safe, accessible, and well-managed.
By proactively communicating updates, reviewing corporate event health protocols, and building flexible COVID contingency plans, meeting planners can protect both attendees and business outcomes in an evolving public health landscape.
Ready to strengthen your event health strategy?
InHouse Physicians partners with meeting planners nationwide to design customized event medical support plans that address evolving COVID-19 policies and protect your attendees. Contact us today to discuss your upcoming conference or corporate event.